arzerra - ofatumumab injection, solution
(Ofatumumab)Novartis Pharmaceuticals Corporation
CD20-directed Cytolytic Antibody [EPC] class drugs
11 results
briumvi - ublituximab injection, solution, concentrate
(Ublituximab)Tg Therapeutics, Inc.Usage: BRIUMVI treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.gazyva - obinutuzumab injection, solution, concentrate
(Obinutuzumab)Genentech, Inc.Usage: GAZYVA treats previously untreated chronic lymphocytic leukemia (with chlorambucil), relapsed or refractory follicular lymphoma after rituximab-containing regimens (with bendamustine), previously untreated stage II bulky, III, or IV follicular lymphoma (with chemotherapy), and active lupus nephritis in adults on standard therapy.kesimpta - ofatumumab injection, solution
(Ofatumumab)Novartis Pharmaceuticals CorporationUsage: Kesimpta treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.ocrevus - ocrelizumab injection
(Ocrelizumab)Genentech, Inc.Usage: Ocrevus treats relapsing forms of MS (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) and primary progressive MS in adults.ocrevus zunovo - ocrelizumab and hyaluronidase injection, solution
(Ocrelizumab And Hyaluronidase)Genentech, Inc.riabni - rituximab - arrx injection, solution
(Rituximab-Arrx)Amgen, Incrituxan - rituximab injection, solution
(Rituximab)Genentech, Inc.Usage: Rituxan treats Non-Hodgkin's Lymphoma (adults and pediatric patients 6+ months), Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis unresponsive to TNF antagonists, Granulomatosis with Polyangiitis and Microscopic Polyangiitis (ages 2+), and moderate-to-severe Pemphigus Vulgaris in adults.rituxan hycela - rituximab and hyaluronidase injection, solution
(Rituximab And Hyaluronidase)Genentech, Inc.Usage: Rituxan Hycela treats adult patients with follicular lymphoma (relapsed/refractory, previously untreated, or non-progressing after CVP), previously untreated diffuse large B-cell lymphoma with chemotherapy, and previously untreated or treated chronic lymphocytic leukemia with fludarabine and cyclophosphamide. Requires prior IV rituximab dose.ruxience - rituximab - pvvr injection, solution
(Rituximab-Pvvr)Pfizer Laboratories Div Pfizer IncUsage: Ruxience treats adult patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis (after TNF antagonist failure), Granulomatosis with Polyangiitis, Microscopic Polyangiitis, and moderate-to-severe Pemphigus Vulgaris.